Skip to content
Back to glossary
Biomarkers

CA-125

CA-125 (cancer antigen 125) is a large mucin-like protein made by the MUC16 gene. It sits on certain body-cavity and reproductive-tract surfaces. It sheds into your blood when those surfaces are disrupted. Clinically, a serum CA-125 above 35 U/mL is used as a tumor marker for epithelial ovarian cancer. It mainly tracks treatment response and catches recurrence. But it is weak for early-stage disease, with sensitivity only around 50%. It is also non-specific. Endometriosis, fibroids, pelvic inflammatory disease, fluid around the lungs, and liver cirrhosis can all push it up without cancer. To improve accuracy, the ROMA algorithm (Risk of Ovarian Malignancy Algorithm) combines CA-125 with another marker, HE4. ROMA is preferred over CA-125 alone for sizing up risk before surgery.

Last reviewed:

This definition is educational and is not medical advice, a diagnosis, or treatment. Talk to a doctor about any health decisions. Read our full medical disclaimer

Sources

  1. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, et al.. (1983). A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. *New England Journal of Medicine*doi:10.1056/NEJM198310133091503